Rewarding Value in funding and reimbursement – Reflection paper

The current paper presents reflections of MedTech Europe, and aims at facilitating the dialogue between industry and funding, and reimbursement decision makers (collectively referred to as “payers”; please see Annex for definition), in order to create an innovation-friendly environment for healthcare in Europe. A desired outcome of the paper would be that reimbursement authorities and the broader payers’ community would reflect on the initial conclusions and recommendations and engage in a dialogue with the Medical Technology Industry in Europe.